TherapeuticsMD
TXMD
TXMD
144 hedge funds and large institutions have $982M invested in TherapeuticsMD in 2017 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 49 increasing their positions, 34 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.02% less ownership
Funds ownership: 1.52% → 1.5% (-0.02%)
63% less call options, than puts
Call options by funds: $2.71M | Put options by funds: $7.26M
Holders
144
Holding in Top 10
–
Calls
$2.71M
Puts
$7.26M
Top Buyers
| 1 | +$20M | |
| 2 | +$18.7M | |
| 3 | +$10.8M | |
| 4 |
First Eagle Investment Management
New York
|
+$9.47M |
| 5 |
AAP
Ardsley Advisory Partners
Stamford,
Connecticut
|
+$6.19M |
Top Sellers
| 1 | -$37M | |
| 2 | -$14.4M | |
| 3 | -$13.4M | |
| 4 |
CCI
Columbus Circle Investors
|
-$10.7M |
| 5 |
LCM
Laurion Capital Management
New York
|
-$3.49M |